Back to search
FDAFDA · Food and drugs·Recall number D-0477-2024

Methylergonovine Maleate Tablets, USP, 0.2mg, 12-count bottle, Rx Only, Distributed by: Amneal Pharmaceuticals, LLC, Bridgewater, NJ 08807, NDC # 69238-1605-2.

Published May 8, 2024 · Recall initiated: March 25, 2024

Summary

FDA records drug Class II recall D-0477-2024, published May 8, 2024 and initiated March 25, 2024. Recalling firm: Amneal Pharmaceuticals of New York, LLC; Status: Completed; Reported quantity: 2784 bottles; Lot: Lot #: BJ01922A, exp. date 03/2024. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications

What to do

Voluntary: Firm initiated · Letter

Get an email if METHYLERGONOVINE MALEATE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
METHYLERGONOVINE MALEATE
Manufacturer
Amneal Pharmaceuticals of New York, LLC
Distributor
US Nationwide.
Lot
Lot #: BJ01922A, exp. date 03/2024
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Methylergonovine Maleate Tablets, USP, 0.2mg, 12-count bottle, Rx Only, Distributed by: Amneal Pharmaceuticals, LLC, Bridgewater, NJ 08807, NDC # 69238-1605-2. recalled?

Yes. FDA published recall D-0477-2024 on May 8, 2024. Reported hazard: Failed Dissolution Specifications

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: METHYLERGONOVINE MALEATE.